NEULAND LABORATORIES
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Neuland Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.29₹ 393.5
As on Nov 4, 2025, 3:17 PM IST
Neuland Laboratories Price Performance
Today's LowToday's High
₹17,147.25₹18,038.65
₹17,544.40
52 Weeks' Low52 Weeks' High
₹10,060.00₹18,089.55
₹17,544.40
Open Price
₹17,200.00
Prev. Close
₹17,150.90
Volume
8,129
Over the last 5 years, the share price of Neuland Laboratories has gained 70.46% CAGR. Over the past year, the corresponding return has been 19.33%.
Neuland Laboratories’s current P/E of 129.66x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Neuland Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Neuland Laboratories | 12.92 | 17.27 | 35.97 | 43.66 | 20.65 | 128.33 | 70.84 |
| Sun Pharmaceutical Industries | -0.13 | 1.88 | 2.68 | -8.18 | -6.84 | 17.47 | 27.29 |
| Divi's Laboratories | 5.94 | 16.97 | 4.95 | 11.11 | 15.59 | 22.08 | 16.36 |
| Torrent Pharmaceuticals | 0.86 | 2.37 | -0.12 | 9.91 | 12.83 | 29.32 | 22.65 |
| Cipla | -4.28 | -0.74 | -0.85 | -2.62 | -5.17 | 9.44 | 13.98 |
| Dr. Reddy's Laboratories | -7.14 | -4.01 | -2.20 | 2.21 | -5.49 | 9.82 | 3.96 |
| Zydus Lifesciences | -2.76 | -2.07 | 1.46 | 9.15 | -3.04 | 30.34 | 17.28 |
| Mankind Pharma | -1.53 | -3.42 | -9.91 | -1.99 | -13.42 | 18.47 | 10.71 |
| Lupin | 3.54 | 2.63 | 5.63 | -4.71 | -9.12 | 40.92 | 16.07 |
| Alkem Laboratories | 4.44 | 3.34 | 15.64 | 11.76 | -2.13 | 20.35 | 16.06 |
| Aurobindo Pharma | 3.90 | 4.22 | 4.73 | -8.07 | -18.82 | 27.32 | 7.88 |
| Abbott India | -1.19 | -1.97 | -13.50 | -4.33 | -0.05 | 14.76 | 13.19 |
| Laurus Labs | 2.49 | 13.91 | 14.15 | 59.07 | 101.74 | 28.39 | 28.82 |
| Glenmark Pharmaceuticals | 2.75 | -5.36 | -10.05 | 32.71 | 9.73 | 64.23 | 30.25 |
| Biocon | 3.09 | 8.62 | -1.37 | 12.31 | 21.29 | 11.23 | -1.68 |
| GlaxoSmithKline Pharmaceuticals | 0.24 | -2.64 | -7.04 | -7.95 | 1.95 | 25.54 | 13.80 |
| Anthem Biosciences | -1.00 | -7.60 | -6.24 | -3.33 | -3.33 | -1.12 | -0.68 |
| Ipca Laboratories | 0.87 | -2.02 | -10.20 | -6.78 | -18.44 | 12.66 | 1.82 |
| Ajanta Pharma | 8.41 | 6.38 | -1.94 | -0.15 | -13.68 | 27.23 | 19.20 |
| Gland Pharma | 0.84 | -1.08 | -3.16 | 35.22 | 19.17 | 1.96 | 1.05 |
Over the last one year, Neuland Laboratories has gained 20.65% compared to peers like Sun Pharmaceutical Industries (-6.84%), Divi's Laboratories (15.59%), Torrent Pharmaceuticals (12.83%). From a 5 year perspective, Neuland Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (27.29%) and Divi's Laboratories (16.36%).
Neuland Laboratories Financials
Neuland Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 15,918.43 | 16,450.03 |
| 10 | 16,076.02 | 16,236.13 |
| 20 | 15,968.95 | 15,991.01 |
| 50 | 15,152.86 | 15,285.63 |
| 100 | 14,065.45 | 14,465.29 |
| 200 | 13,163.27 | 13,523.55 |
Neuland Laboratories Share Holding Pattern
In the latest quarter, Neuland Laboratories saw a drop in promoter holding to 32.64%, while DII stake increased to 13.55%, FII holding fell to 20.60%, and public shareholding moved down to 32.80% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Neuland Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,66,718 | 1.52 | 243.49 | |
| 44,855 | 1.96 | 65.51 | |
| 36,000 | 0.92 | 52.58 | |
| 25,605 | 0.6 | 37.4 | |
| 19,136 | 0.22 | 27.95 | |
| 12,500 | 1.17 | 18.26 | |
| 6,653 | 1.54 | 9.72 | |
| 5,700 | 0.88 | 8.32 | |
| 5,576 | 0.6 | 8.14 | |
| 5,056 | 0.68 | 7.38 |
* Excluding Index & Arbitrage Funds
Neuland Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 28, 2025, 2:46 PM IST | Neuland Laborat - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 24, 2025, 10:39 PM IST | Neuland Laborat - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For T |
| Oct 17, 2025, 9:15 PM IST | Neuland Laborat - Re-Lodgement Of Transfer Request Of Physical Shares |
| Oct 06, 2025, 9:00 PM IST | Neuland Laborat - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
| Oct 06, 2025, 8:16 PM IST | Neuland Laborat - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Neuland Laboratories
Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1476.84 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address11th Floor (5th Office Level), Phoenix IVY Building, Hyderabad Telangana 500033
- Contact
Management
- Dr. Davuluri Rama Mohan RaoExecutive Chairman
- Mr. Davuluri Sucheth RaoVice Chairman & CEO
- Mr. Davuluri Saharsh RaoVice Chairman & Mng.Director
- Dr. Christopher M CimarustiNon Executive Director
- Mr. Homi Rustum KhusrokhanInd. Non-Executive Director
- Mr. Prasad Raghava MenonInd. Non-Executive Director
- Mr. Sugata SircarInd. Non-Executive Director
- Ms. Pallavi Joshi BakhruInd. Non-Executive Director
FAQs on Neuland Laboratories Share Price
What is the share price of Neuland Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Neuland Laboratories is ₹17,544.40 as on Nov 04, 2025.
What kind of stock is Neuland Laboratories?
The Neuland Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Neuland Laboratories?
The market cap of Neuland Laboratories is ₹22,837.52 Cr as on Nov 04, 2025.
What are today's High and Low prices of Neuland Laboratories?
Today’s highest and lowest price of Neuland Laboratories are ₹18,038.65 and ₹17,147.25.
What are the 52 Week High and 52 Week Low of Neuland Laboratories?
The 52-week high/low is the highest and lowest price at which Neuland Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Neuland Laboratories is ₹18,089.55 and 52-week low of Neuland Laboratories is ₹10,060.00 as on Nov 04, 2025.
How has the Neuland Laboratories performed historically in terms of returns?
The Neuland Laboratories has shown returns of 2.5% over the past day, 15.99% for the past month, 34.48% over 3 months, 19.33% over 1 year, 127.5% across 3 years, and 70.46% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Neuland Laboratories?
P/E ratio of and PB ratio of Neuland Laboratories are 129.66 and 16.37 on Nov 04, 2025. While the company gives a dividend yield of 0.07 per annum.
✕
Market Pulse